VEGFR2/CD309 antibody
-
- Target See all VEGFR2/CD309 (VEGFR2) Antibodies
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Reactivity
- Mouse
-
Host
- Rat
-
Clonality
- Monoclonal
-
Conjugate
- This VEGFR2/CD309 antibody is un-conjugated
-
Application
- Flow Cytometry (FACS), Immunoprecipitation (IP)
- Purification
- Purified by affinity chromatography.
- Clone
- Avas12a1
- Isotype
- IgG2a kappa
- Top Product
- Discover our top product VEGFR2 Primary Antibody
-
-
- Application Notes
-
FC: ≤ 1 μg/test
Optimal working dilution should be determined by the investigator. - Restrictions
- For Research Use only
-
- Concentration
- Lot specific
- Buffer
- In aqueous buffer with 0.09 % sodium azide, may contain carrier prote/stabilizer.
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Avoid repeated freeze/thaw cycles
- Storage
- 4 °C
- Storage Comment
- Store at 2-8 °C. Do not freeze. Protect from light
-
-
The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis." in: Developmental cell, Vol. 25, Issue 2, pp. 156-68, (2013) (PubMed).
: "VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis." in: Developmental cell, Vol. 18, Issue 5, pp. 713-24, (2010) (PubMed).
: "
-
The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis." in: Developmental cell, Vol. 25, Issue 2, pp. 156-68, (2013) (PubMed).
-
- Target
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
- Alternative Name
- Flk1 (VEGFR2 Products)
- Pathways
- RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
-